|
PDLI holds the patent rights to synagis and will hold the patent on successor drug now in clinical trials. We don't know what future drugs may be developed which would entitle PDLI to patents rights.
Sentiment : Hold Rating :
 (No ratings) |
68/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
1.74